{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:36:28Z","timestamp":1792773388199,"version":"4.5.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Taishan Scholars Project of Shandong Province","award":["tsqn202211365"],"award-info":[{"award-number":["tsqn202211365"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05238-6","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:34:54Z","timestamp":1781073294000},"page":"4893-4907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From AKI to CKD mechanisms of maladaptive repair and disease progression"],"prefix":"10.1007","volume":"58","author":[{"given":"Qiming","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxia","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-2823","authenticated-orcid":false,"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"1","key":"5238_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41419-025-08268-7","volume":"17","author":"P Gao","year":"2025","unstructured":"Gao P, Cenatus S, Henley N et al (2025) Inhibition of MCL-1 to eliminate senescent cells and mitigate renal fibrosis in aristolochic acid nephropathy. Cell Death Dis 17(1):56","journal-title":"Cell Death Dis"},{"issue":"3","key":"5238_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102583","volume":"36","author":"C Cui","year":"2025","unstructured":"Cui C, Cui F, Zou Q, Zhang Z, Jia L (2025) Progress and applications of single-cell RNA sequencing and spatial transcriptome technology in acute kidney injury research. Mol Ther Nucleic Acids 36(3):102583","journal-title":"Mol Ther Nucleic Acids"},{"key":"5238_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.667282","volume":"12","author":"Q Kuang","year":"2021","unstructured":"Kuang Q, Wu S, Xue N, Wang X, Ding X, Fang Y (2021) Selective Wnt\/\u03b2-catenin pathway activation concomitant with sustained overexpression of miR-21 is responsible for aristolochic acid-Induced AKI-to-CKD transition. Front Pharmacol 12:667282","journal-title":"Front Pharmacol"},{"issue":"4","key":"5238_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/MNH.0000000000000504","volume":"28","author":"A Zuk","year":"2019","unstructured":"Zuk A, Bonventre JV (2019) Recent advances in acute kidney injury and its consequences and impact on chronic kidney disease. Curr Opin Nephrol Hypertens 28(4):397\u2013405","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"5238_CR5","doi-asserted-by":"publisher","first-page":"9029868","DOI":"10.1155\/2020\/9029868","volume":"2020","author":"JY Zhao","year":"2020","unstructured":"Zhao JY, Wu YB (2020) Huaier extract attenuates acute kidney injury to chronic kidney disease transition by inhibiting endoplasmic reticulum stress and apoptosis via miR-1271 upregulation. Biomed Res Int 2020:9029868","journal-title":"Biomed Res Int"},{"issue":"3","key":"5238_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/ckj\/sfaa177","volume":"14","author":"J Gameiro","year":"2021","unstructured":"Gameiro J, Marques F, Lopes JA (2021) Long-term consequences of acute kidney injury: a narrative review. Clin Kidney J 14(3):789\u2013804","journal-title":"Clin Kidney J"},{"key":"5238_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.678524","volume":"9","author":"CE Higgins","year":"2021","unstructured":"Higgins CE, Tang J, Higgins SP et al (2021) The genomic response to TGF-\u03b21 dictates failed repair and progression of fibrotic disease in the obstructed kidney. Front Cell Dev Biol 9:678524","journal-title":"Front Cell Dev Biol"},{"key":"5238_CR8","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.12865","author":"ML Kristensen","year":"2016","unstructured":"Kristensen ML, Kierulf-Lassen C, Nielsen PM, Kristensen MLV et al (2016) Remote ischemic perconditioning attenuates ischemia\/reperfusion-induced downregulation of AQP2 in rat kidney. Physiol Rep. https:\/\/doi.org\/10.14814\/phy2.12865","journal-title":"Physiol Rep"},{"issue":"4","key":"5238_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00280-024-04705-0","volume":"94","author":"T Skajaa","year":"2024","unstructured":"Skajaa T, Faerch M, Hasle H (2024) Acute kidney injury in a child treated with cisplatin and amphotericin B. Cancer Chemother Pharmacol 94(4):623\u2013626","journal-title":"Cancer Chemother Pharmacol"},{"key":"5238_CR10","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19481","volume":"13","author":"Z Han","year":"2025","unstructured":"Han Z, Deng T, Yan D, Jia Y, Tang J, Wang X (2025) Hydrogen sulfide protects against cisplatin-induced experimental nephrotoxicity in animal models: a systematic review and meta-analysis. PeerJ 13:e19481","journal-title":"PeerJ"},{"key":"5238_CR11","doi-asserted-by":"publisher","first-page":"1280951","DOI":"10.3389\/fmed.2023.1280951","volume":"10","author":"D Holmes","year":"2023","unstructured":"Holmes D, Colaneri M, Palomba E, Gori A (2023) Exploring post-SEPSIS and post-COVID-19 syndromes: crossovers from pathophysiology to therapeutic approach. Front Med (Lausanne) 10:1280951","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"5238_CR12","doi-asserted-by":"publisher","first-page":"F979","DOI":"10.1152\/ajprenal.00281.2020","volume":"319","author":"YD Kwong","year":"2020","unstructured":"Kwong YD, Mehta KM, Miaskowski C et al (2020) Using best subset regression to identify clinical characteristics and biomarkers associated with sepsis-associated acute kidney injury. Am J Physiol Renal Physiol 319(6):F979\u2013F987","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"5238_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.25259\/IJMR_2037_2024","volume":"161","author":"SS Malla","year":"2025","unstructured":"Malla SS, Kola VR, Agiwal V, Pant HB (2025) Prevalence and risk factors of multi-morbidity in critically ill patients with sepsis-associated acute kidney injury (SA-AKI). Indian J Med Res 161(6):665\u2013671","journal-title":"Indian J Med Res"},{"issue":"6","key":"5238_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf169","volume":"18","author":"J Gameiro","year":"2025","unstructured":"Gameiro J, Gouveia B, Fonseca JA, Lopes JA (2025) The burden of acute kidney disease: an epidemiological review and importance of follow-up care. Clin Kidney J 18(6):sfaf169","journal-title":"Clin Kidney J"},{"issue":"4","key":"5238_CR15","first-page":"427","volume":"63","author":"S Alizadeh","year":"2019","unstructured":"Alizadeh S, Esmaeili H, Alizadeh M et al (2019) Metabolic phenotypes of obese, overweight, and normal weight individuals and risk of chronic kidney disease: a systematic review and meta-analysis. Arch Endocrinol Metab 63(4):427\u2013437","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"5238_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40519-024-01697-x","volume":"29","author":"M Valizadeh","year":"2024","unstructured":"Valizadeh M, Ahmadi AR, Abbaspour F et al (2024) The risk of kidney dysfunction in metabolically healthy\/unhealthy population with normal weight or overweight\/obesity: a systematic review and meta-analysis. Eat Weight Disord 29(1):69","journal-title":"Eat Weight Disord"},{"issue":"3","key":"5238_CR17","doi-asserted-by":"publisher","first-page":"F793","DOI":"10.1152\/ajprenal.00367.2019","volume":"318","author":"L Liu","year":"2020","unstructured":"Liu L, Deng Y, Cai Y et al (2020) Ablation of Gsa impairs renal tubule proliferation after injury via CDK2\/cyclin E. Am J Physiol Renal Physiol 318(3):F793\u2013F803","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"5238_CR18","first-page":"4040","volume":"8","author":"YL Shen","year":"2016","unstructured":"Shen YL, Sun L, Hu YJ et al (2016) P53 inhibitor pifithrin-\u03b1 prevents the renal tubular epithelial cells against injury. Am J Transl Res 8(10):4040\u20134053","journal-title":"Am J Transl Res"},{"key":"5238_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116035","author":"Y Li","year":"2022","unstructured":"Li Y, Ricardo SD, Samuel CS (2022) Enhancing the therapeutic potential of mesenchymal stromal cell-based therapies with an anti-fibrotic agent for the treatment of chronic kidney disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23116035","journal-title":"Int J Mol Sci"},{"issue":"11","key":"5238_CR20","first-page":"1314","volume":"22","author":"G Mercanoglu","year":"2019","unstructured":"Mercanoglu G, Semen O (2019) Nitric oxide mediated the effects of nebivolol in cardiorenal syndrome. Iran J Basic Med Sci 22(11):1314\u20131324","journal-title":"Iran J Basic Med Sci"},{"key":"5238_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.945827","volume":"13","author":"Y Du","year":"2022","unstructured":"Du Y, Hao H, Ma H, Liu H (2022) Macrophage migration inhibitory factor in acute kidneyinjury. Front Physiol 13:945827","journal-title":"Front Physiol"},{"issue":"1","key":"5238_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41420-021-00719-2","volume":"7","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Xu K, Li C et al (2021) NLRP3 associated with chronic kidney disease progression after ischemia\/reperfusion-induced acute kidney injury. Cell Death Discov 7(1):324","journal-title":"Cell Death Discov"},{"issue":"1","key":"5238_CR23","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1038\/s41467-023-38771-4","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) HDAC9-mediated epithelial cell cycle arrest in G2\/M contributes to kidney fibrosis in male mice. Nat Commun 14(1):3007","journal-title":"Nat Commun"},{"key":"5238_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011093","author":"L De Chiara","year":"2021","unstructured":"De Chiara L, Conte C, Antonelli G, Lazzeri E (2021) Tubular cell cycle response upon AKI: revising old and new paradigms to identify novel targets for CKD prevention. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222011093","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5238_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.23876\/j.krcp.22.211","volume":"42","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Jiang L, Su T, Liu G, Yang L (2023) Overview of aristolochic acid nephropathy: an update. Kidney Research and Clinical Practice 42(5):579\u2013590","journal-title":"Kidney Research and Clinical Practice"},{"issue":"1","key":"5238_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00018-025-05688-8","volume":"82","author":"X Cai","year":"2025","unstructured":"Cai X, Cao H, Wang M et al (2025) SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2. Cell Mol Life Sci 82(1):159","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"5238_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/ki.2015.293","volume":"89","author":"Y Yan","year":"2016","unstructured":"Yan Y, Ma L, Zhou X et al (2016) Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis. Kidney Int 89(1):68\u201381","journal-title":"Kidney Int"},{"issue":"1","key":"5238_CR28","doi-asserted-by":"publisher","first-page":"12059","DOI":"10.1038\/s41598-019-48557-8","volume":"9","author":"T Koyano","year":"2019","unstructured":"Koyano T, Namba M, Kobayashi T, Nakakuni K, Nakano D, Fukushima M, Nishiyama A, Matsuyama M (2019) The p21 dependent G2 arrest of the cell cycle in epithelial tubular cells links to the early stage of renal fibrosis. Sci Rep 9(1):12059","journal-title":"Sci Rep"},{"issue":"19","key":"5238_CR29","doi-asserted-by":"publisher","first-page":"10830","DOI":"10.1073\/pnas.96.19.10830","volume":"96","author":"J Megyesi","year":"1999","unstructured":"Megyesi J et al (1999) The lack of a functional p21(WAF1\/CIP1) gene ameliorates progression to chronic renal failure. Proc Natl Acad Sci U S A 96(19):10830\u201310835","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"5238_CR30","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1046\/j.1523-1755.2001.00044.x","volume":"60","author":"J Megyesi","year":"2001","unstructured":"Megyesi J et al (2001) Positive effect of the induction of p21WAF1\/CIP1 on the course of ischemic acute renal failure. Kidney Int 60(6):2164\u20132172","journal-title":"Kidney Int"},{"issue":"4","key":"5238_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1172\/JCI1497","volume":"101","author":"J Megyesi","year":"1998","unstructured":"Megyesi J, Safirstein RL, Price PM (1998) Induction of p21WAF1\/CIP1\/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101(4):777\u2013782","journal-title":"J Clin Invest"},{"key":"5238_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163846","author":"BD Humphreys","year":"2022","unstructured":"Humphreys BD (2022) Decoupling dedifferentiation and G2\/M arrest in kidney fibrosis. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI163846","journal-title":"J Clin Invest"},{"issue":"1","key":"5238_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40659-024-00490-5","volume":"57","author":"E Perez-Moreno","year":"2024","unstructured":"Perez-Moreno E, Oyanadel C, de la Pe\u00f1a A et al (2024) Galectins in epithelial-mesenchymal transition: roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis. Biol Res 57(1):14","journal-title":"Biol Res"},{"issue":"5","key":"5238_CR34","doi-asserted-by":"publisher","first-page":"6782","DOI":"10.18632\/aging.202537","volume":"13","author":"H Liu","year":"2021","unstructured":"Liu H, Yan R, Liang L et al (2021) The role of CDX2 in renal tubular lesions during diabetic kidney disease. Aging (Albany NY) 13(5):6782\u20136803","journal-title":"Aging (Albany NY)"},{"key":"5238_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.737570","volume":"12","author":"S Lovisa","year":"2021","unstructured":"Lovisa S (2021) Epithelial-to-mesenchymal transition in fibrosis: concepts and targeting strategies. Front Pharmacol 12:737570","journal-title":"Front Pharmacol"},{"key":"5238_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020949","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yang J, Zhang Y, Zhou J (2024) Focus on mitochondrial respiratory chain: potential therapeutic target for chronic renal failure. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25020949","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5238_CR37","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.7150\/thno.92848","volume":"14","author":"S Zhou","year":"2024","unstructured":"Zhou S, Ling X, Zhu J, Zhou L et al (2024) MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity. Theranostics 14(4):1583\u20131601","journal-title":"Theranostics"},{"key":"5238_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.788977","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Jiang B, Zou Y, Zhang J, Fu YY, Zhai XY (2021) Roxadustat (FG-4592) facilitates recovery from renal damage by ameliorating mitochondrial dysfunction induced by folic acid. Front Pharmacol 12:788977","journal-title":"Front Pharmacol"},{"key":"5238_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1623500","volume":"16","author":"M Cao","year":"2025","unstructured":"Cao M, Zhao X, Xia F, Zhao D et al (2025) Mitochondrial dysfunction and metabolic reprogramming in acute kidney injury: mechanisms, therapeutic advances, and clinical challenges. Front Physiol 16:1623500","journal-title":"Front Physiol"},{"key":"5238_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02162","volume":"10","author":"G Lorenz","year":"2019","unstructured":"Lorenz G, Moschovaki-Filippidou F, W\u00fcrf V et al (2019) IFN Regulatory factor 4 controls post-ischemic inflammation and prevents chronic kidney disease. Front Immunol 10:2162","journal-title":"Front Immunol"},{"key":"5238_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.934299","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen H, Liu N, Zhuang S (2022) Macrophages in renal injury, repair, fibrosis following acute kidney injury and targeted therapy. Front Immunol 13:934299","journal-title":"Front Immunol"},{"issue":"7","key":"5238_CR42","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/CM9.0000000000002100","volume":"135","author":"X Meng","year":"2022","unstructured":"Meng X, Jin J, Lan HY (2022) Driving role of macrophages in transition from acute kidney injury to chronic kidney disease. Chin Med J (Engl) 135(7):757\u2013766","journal-title":"Chin Med J (Engl)"},{"key":"5238_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1385696","volume":"15","author":"C Wang","year":"2024","unstructured":"Wang C, Zhang Y, Shen A et al (2024) Mincle receptor in macrophage and neutrophil contributes to the unresolved inflammation during the transition from acute kidney injury to chronic kidney disease. Front Immunol 15:1385696","journal-title":"Front Immunol"},{"key":"5238_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1530741","volume":"12","author":"X Cai","year":"2025","unstructured":"Cai X, Li X, Shi J et al (2025) S100A8\/A9 high-expression macrophages mediate renal tubular epithelial cell damage in acute kidney injury following acute type A aortic dissection surgery. Front Mol Biosci 12:1530741","journal-title":"Front Mol Biosci"},{"key":"5238_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061801","author":"C Atri","year":"2018","unstructured":"Atri C, Guerfali FZ, Laouini D (2018) Role of human macrophage polarization in inflammation during infectious diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19061801","journal-title":"Int J Mol Sci"},{"key":"5238_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12091942","author":"H Wu","year":"2024","unstructured":"Wu H, Qiu Z, Wang L, Li W (2024) Renal fibrosis: SIRT1 still of value. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12091942","journal-title":"Biomedicines"},{"issue":"1","key":"5238_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L (2023) Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther 8(1):129","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5238_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04222-z","volume":"26","author":"X Kang","year":"2025","unstructured":"Kang X, Gu Q, Cheng X, Jia J, Yan T (2025) Inhibition of Axl attenuates acute kidney injury by alleviating inflammation via SOCS3 downregulation in tubular epithelial cells. BMC Nephrol 26(1):325","journal-title":"BMC Nephrol"},{"key":"5238_CR49","doi-asserted-by":"publisher","first-page":"1008727","DOI":"10.3389\/fimmu.2022.1008727","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li X, Xu X et al (2022) Clec7a expression in inflammatory macrophages orchestrates progression of acute kidney injury. Front Immunol 13:1008727","journal-title":"Front Immunol"},{"issue":"4","key":"5238_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13005","volume":"54","author":"Y Xu","year":"2021","unstructured":"Xu Y, Li D, Wu J et al (2021) Farnesoid X receptor promotes renal ischaemia-reperfusion injury by inducing tubular epithelial cell apoptosis. Cell Prolif 54(4):e13005","journal-title":"Cell Prolif"},{"issue":"4","key":"5238_CR51","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1681\/ASN.2012080871","volume":"24","author":"Y Kida","year":"2013","unstructured":"Kida Y, Ieronimakis N, Schrimpf C, Reyes M, Duffield JS (2013) EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury. J Am Soc Nephrol 24(4):559\u2013572","journal-title":"J Am Soc Nephrol"},{"key":"5238_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103942","volume":"77","author":"B Wang","year":"2022","unstructured":"Wang B, Li ZL, Zhang YL, Wen Y, Gao YM, Liu BC (2022) Hypoxia and chronic kidney disease. EBioMedicine 77:103942","journal-title":"EBioMedicine"},{"issue":"1","key":"5238_CR53","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1186\/s12967-025-07350-0","volume":"23","author":"S Chai","year":"2025","unstructured":"Chai S, Zeng Z, Shang J et al (2025) Histone modification-mediated epigenetic regulation in AKI-to-CKD transition: a cell-type-specific perspective. J Transl Med 23(1):1346","journal-title":"J Transl Med"},{"issue":"4","key":"5238_CR54","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.semnephrol.2004.04.003","volume":"24","author":"MS Goligorsky","year":"2004","unstructured":"Goligorsky MS, Brodsky SV, Noiri E (2004) NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology. Semin Nephrol 24(4):316\u2013323","journal-title":"Semin Nephrol"},{"key":"5238_CR55","doi-asserted-by":"publisher","first-page":"1256375","DOI":"10.3389\/fendo.2023.1256375","volume":"14","author":"C Guo","year":"2023","unstructured":"Guo C, Cui Y, Jiao M et al (2023) Crosstalk between proximal tubular epithelial cells and other interstitial cells in tubulointerstitial fibrosis after renal injury. Front Endocrinol (Lausanne) 14:1256375","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5238_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105294","volume":"107","author":"ZL Li","year":"2024","unstructured":"Li ZL, Li XY, Zhou Y, Wang B, Lv LL, Liu BC (2024) Renal tubular epithelial cells response to injury in acute kidney injury. EBioMedicine 107:105294","journal-title":"EBioMedicine"},{"issue":"11","key":"5238_CR57","doi-asserted-by":"publisher","first-page":"F1187","DOI":"10.1152\/ajprenal.00425.2014","volume":"307","author":"S Tanaka","year":"2014","unstructured":"Tanaka S, Tanaka T, Nangaku M (2014) Hypoxia as a key player in the AKI-to-CKD transition. Am J Physiol Renal Physiol 307(11):F1187\u2013F1195","journal-title":"Am J Physiol Renal Physiol"},{"key":"5238_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.746920","volume":"8","author":"X Zhu","year":"2021","unstructured":"Zhu X, Jiang L, Long M, Wei X, Hou Y, Du Y (2021) Metabolic reprogramming and renal fibrosis. Front Med (Lausanne) 8:746920","journal-title":"Front Med (Lausanne)"},{"key":"5238_CR59","doi-asserted-by":"publisher","first-page":"1329644","DOI":"10.3389\/fphys.2024.1329644","volume":"15","author":"T Wang","year":"2024","unstructured":"Wang T, Huang Y, Zhang X, Zhang Y, Zhang X (2024) Advances in metabolic reprogramming of renal tubular epithelial cells in sepsis-associated acute kidney injury. Front Physiol 15:1329644","journal-title":"Front Physiol"},{"issue":"6","key":"5238_CR60","first-page":"680","volume":"31","author":"Y Vogelaar","year":"2025","unstructured":"Vogelaar Y, Mourisse L, Pickkers P (2025) The therapeutic horizon of acute kidney injury in critical care: exploring pathology, promises, pitfalls, and progress. Curr Opin Crit Care 31(6):680\u2013691","journal-title":"Curr Opin Crit Care"},{"key":"5238_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.742072","volume":"8","author":"A Faivre","year":"2021","unstructured":"Faivre A, Verissimo T, Auwerx H, Legouis D, de Seigneux S (2021) Tubular cell glucose metabolism shift during acute and chronic injuries. Front Med (Lausanne) 8:742072","journal-title":"Front Med (Lausanne)"},{"key":"5238_CR62","doi-asserted-by":"publisher","first-page":"1094556","DOI":"10.3389\/fimmu.2022.1094556","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Li Q, Ling Y et al (2022) m6A eraser FTO modulates autophagy by targeting SQSTM1\/P62 in the prevention of canagliflozin against renal fibrosis. Front Immunol 13:1094556","journal-title":"Front Immunol"},{"issue":"11","key":"5238_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107906","volume":"300","author":"SJ Kierans","year":"2024","unstructured":"Kierans SJ, Taylor CT (2024) Glycolysis: A multifaceted metabolic pathway and signaling hub. J Biol Chem 300(11):107906","journal-title":"J Biol Chem"},{"key":"5238_CR64","doi-asserted-by":"publisher","first-page":"1003227","DOI":"10.3389\/fmolb.2022.1003227","volume":"9","author":"F Tanemoto","year":"2022","unstructured":"Tanemoto F, Nangaku M, Mimura I (2022) Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition. Front Mol Biosci 9:1003227","journal-title":"Front Mol Biosci"},{"key":"5238_CR65","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1038\/ncomms4550","volume":"5","author":"M Khacho","year":"2014","unstructured":"Khacho M, Tarabay M, Patten D et al (2014) Acidosis overrides oxygen deprivation to maintain mitochondrial function and cell survival. Nat Commun 5:3550","journal-title":"Nat Commun"},{"issue":"29","key":"5238_CR66","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt1318","volume":"11","author":"P Lou","year":"2025","unstructured":"Lou P, Zhou X, Zhang Y et al (2025) Harnessing tissue-derived mitochondria-rich extracellular vesicles (Ti-mitoEVs) to boost mitochondrial biogenesis for regenerative medicine. Sci Adv 11(29):eadt1318","journal-title":"Sci Adv"},{"key":"5238_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103269","volume":"75","author":"JH Lee","year":"2024","unstructured":"Lee JH (2024) Oxidative stress and the multifaceted roles of ATM in maintaining cellular redox homeostasis. Redox Biol 75:103269","journal-title":"Redox Biol"},{"issue":"1","key":"5238_CR68","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40001-025-03590-4","volume":"31","author":"K Yang","year":"2025","unstructured":"Yang K, Zhao Q, Sun Y, Lin L, Han X (2025) Mitochondrial immunometabolism in sepsis: orchestrating macrophage polarization and dysfunction. Eur J Med Res 31(1):36","journal-title":"Eur J Med Res"},{"key":"5238_CR69","doi-asserted-by":"publisher","first-page":"1166214","DOI":"10.3389\/fimmu.2023.1166214","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen S, Liao Z, Xu P (2023) Mitochondrial control of innate immune responses. Front Immunol 14:1166214","journal-title":"Front Immunol"},{"issue":"3","key":"5238_CR70","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10522-025-10256-5","volume":"26","author":"A Picos","year":"2025","unstructured":"Picos A, Seoane N, Campos-Toimil M, Vi\u00f1a D (2025) Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects. Biogerontology 26(3):118","journal-title":"Biogerontology"},{"issue":"7","key":"5238_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18134","volume":"9","author":"J Chen","year":"2023","unstructured":"Chen J, Zheng QY, Wang LM, Luo J, Chen KH, He YN (2023) Proteomics reveals defective peroxisomal fatty acid oxidation during the progression of acute kidney injury and repair. Heliyon 9(7):e18134","journal-title":"Heliyon"},{"key":"5238_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.751529","volume":"8","author":"H Wang","year":"2021","unstructured":"Wang H, Zhang S, Guo J (2021) Lipotoxic proximal tubular injury: a primary event in diabetic kidney disease. Front Med (Lausanne) 8:751529","journal-title":"Front Med (Lausanne)"},{"key":"5238_CR73","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12305","author":"Y Zhan","year":"2021","unstructured":"Zhan Y, Zhu M, Liu S et al (2021) MicroRNA\u201193 inhibits the apoptosis and inflammatory response of tubular epithelial cells via the PTEN\/AKT\/mTOR pathway in acute kidney injury. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12305","journal-title":"Mol Med Rep"},{"key":"5238_CR74","doi-asserted-by":"publisher","first-page":"1700004","DOI":"10.3389\/fimmu.2025.1700004","volume":"16","author":"Y Luo","year":"2025","unstructured":"Luo Y, Long M, Wu X, Zeng L (2025) Targeting ferroptosis: novel therapeutic approaches and intervention strategies for kidney diseases. Front Immunol 16:1700004","journal-title":"Front Immunol"},{"issue":"5","key":"5238_CR75","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","volume":"23","author":"G van Loo","year":"2023","unstructured":"van Loo G, Bertrand M (2023) Death by TNF: a road to inflammation. Nat Rev Immunol 23(5):289\u2013303","journal-title":"Nat Rev Immunol"},{"key":"5238_CR76","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fphys.2013.00272","volume":"4","author":"A Kondratskyi","year":"2013","unstructured":"Kondratskyi A, Yassine M, Kondratska K, Skryma R, Slomianny C, Prevarskaya N (2013) Calcium-permeable ion channels in control of autophagy and cancer. Front Physiol 4:272","journal-title":"Front Physiol"},{"key":"5238_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.619730","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu Z, Shu S, Cai J, Tang C, Dong Z (2020) AMPK\/mTOR signaling in autophagy regulation during cisplatin-induced acute kidney injury. Front Physiol 11:619730","journal-title":"Front Physiol"},{"issue":"15","key":"5238_CR78","doi-asserted-by":"publisher","first-page":"8276","DOI":"10.1111\/jcmm.15301","volume":"24","author":"HJ Zheng","year":"2020","unstructured":"Zheng HJ, Zhang X, Guo J et al (2020) Lysosomal dysfunction-induced autophagic stress in diabetic kidney disease. J Cell Mol Med 24(15):8276\u20138290","journal-title":"J Cell Mol Med"},{"issue":"3","key":"5238_CR79","doi-asserted-by":"publisher","first-page":"166","DOI":"10.18632\/aging.100444","volume":"4","author":"A Salminen","year":"2012","unstructured":"Salminen A, Kaarniranta K, Kauppinen A (2012) Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) 4(3):166\u2013175","journal-title":"Aging (Albany NY)"},{"key":"5238_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2026.156367","volume":"279","author":"J Patel","year":"2026","unstructured":"Patel J, Parab SB, Doshi GM (2026) Endoplasmic reticulum stress and the unfolded protein response in ischemic nephropathy: Pathogenic mechanisms and emerging therapeutic strategies. Pathol Res Pract 279:156367","journal-title":"Pathol Res Pract"},{"key":"5238_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11071356","author":"M Fontecha-Barriuso","year":"2022","unstructured":"Fontecha-Barriuso M, Lopez-Diaz AM, Guerrero-Mauvecin J et al (2022) Tubular mitochondrial dysfunction, oxidative stress, and progression of chronic kidney disease. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox11071356","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"5238_CR82","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41581-025-00938-1","volume":"21","author":"JH Byun","year":"2025","unstructured":"Byun JH, Lebeau PF, Trink J et al (2025) Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease. Nat Rev Nephrol 21(5):299\u2013313","journal-title":"Nat Rev Nephrol"},{"key":"5238_CR83","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fncel.2014.00213","volume":"8","author":"N Chaudhari","year":"2014","unstructured":"Chaudhari N, Talwar P, Parimisetty A, Lefebvre d\u2019Hellencourt C, Ravanan P (2014) A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Front Cell Neurosci 8:213","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"5238_CR84","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12882-025-04179-z","volume":"26","author":"L Liu","year":"2025","unstructured":"Liu L, Ni S, Zhang L, Chen Y, Xie M, Huang X (2025) Molecular insights and clinical implications of DNA methylation in sepsis-associated acute kidney injury: a narrative review. BMC Nephrol 26(1):253","journal-title":"BMC Nephrol"},{"key":"5238_CR85","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/bs.mcb.2019.04.015","volume":"153","author":"LX Li","year":"2019","unstructured":"Li LX, Agborbesong E, Zhang L, Li X (2019) Investigation of epigenetics in kidney cell biology. Methods Cell Biol 153:255\u2013278","journal-title":"Methods Cell Biol"},{"issue":"7","key":"5238_CR86","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2009.06.001","volume":"137","author":"JE Phillips","year":"2009","unstructured":"Phillips JE, Corces VG (2009) CTCF: master weaver of the genome. Cell 137(7):1194\u20131211","journal-title":"Cell"},{"issue":"32","key":"5238_CR87","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado2849","volume":"10","author":"Y Muto","year":"2024","unstructured":"Muto Y, Dixon EE, Yoshimura Y et al (2024) Epigenetic reprogramming driving successful and failed repair in acute kidney injury. Sci Adv 10(32):eado2849","journal-title":"Sci Adv"},{"issue":"8","key":"5238_CR88","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ndt\/gft101","volume":"28","author":"RA Zager","year":"2013","unstructured":"Zager RA (2013) \u2018Biologic memory\u2019 in response to acute kidney injury: cytoresistance, toll-like receptor hyper-responsiveness and the onset of progressive renal disease. Nephrol Dial Transplant 28(8):1985\u20131993","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"5238_CR89","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1007\/s10157-025-02745-1","volume":"29","author":"G Kwoun","year":"2025","unstructured":"Kwoun G, Nangaku M, Mimura I (2025) Epigenetic memories induced by hypoxia in AKI-to-CKD transition. Clin Exp Nephrol 29(12):1712\u20131723. https:\/\/doi.org\/10.1007\/s10157-025-02745-1","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"5238_CR90","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrneph.2015.3","volume":"11","author":"DA Ferenbach","year":"2015","unstructured":"Ferenbach DA, Bonventre JV (2015) Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol 11(5):264\u2013276","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"5238_CR91","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13148-021-01079-5","volume":"13","author":"W Zheng","year":"2021","unstructured":"Zheng W, Guo J, Liu ZS (2021) Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective. Clin Epigenetics 13(1):87","journal-title":"Clin Epigenetics"},{"issue":"9","key":"5238_CR92","doi-asserted-by":"publisher","first-page":"ITC66","DOI":"10.7326\/AITC201711070","volume":"167","author":"AS Levey","year":"2017","unstructured":"Levey AS, James MT (2017) Acute kidney injury. Ann Intern Med 167(9):ITC66\u2013ITC80","journal-title":"Ann Intern Med"},{"key":"5238_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115600","author":"K Nishida","year":"2021","unstructured":"Nishida K, Watanabe H, Murata R et al (2021) Recombinant long-acting thioredoxin ameliorates AKI to CKD transition via modulating renal oxidative stress and inflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22115600","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5238_CR94","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MNH.0000000000000605","volume":"29","author":"SM Yu","year":"2020","unstructured":"Yu SM, Bonventre JV (2020) Acute kidney injury and maladaptive tubular repair leading to renal fibrosis. Curr Opin Nephrol Hypertens 29(3):310\u2013318. https:\/\/doi.org\/10.1097\/MNH.0000000000000605","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"5238_CR95","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nm.2144","volume":"16","author":"L Yang","year":"2010","unstructured":"Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV (2010) Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury. Nat Med 16(5):535\u2013543. https:\/\/doi.org\/10.1038\/nm.2144","journal-title":"Nat Med"},{"issue":"9","key":"5238_CR96","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3902","volume":"21","author":"S Lovisa","year":"2015","unstructured":"Lovisa S, LeBleu VS, Tampe B, Sugimoto H, Vadnagara K, Carstens JL, Wu CC, Hagos Y, Burckhardt BC, Pentcheva-Hoang T, Nischal H, Allison JP, Zeisberg M, Kalluri R (2015) Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med 21(9):998\u20131009. https:\/\/doi.org\/10.1038\/nm.3902","journal-title":"Nat Med"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05238-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:02:09Z","timestamp":1792767729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05238-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":96,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["5238"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05238-6","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}